Home›Stock Screener›IPCA Laboratories›Quarterly Results

IPCA Laboratories Quarterly Results

Latest Quarter Net Profit
₹389 Cr
QSept 2026
Quarterly Results

IPCA Laboratories quarterly results. In Sept 2026, IPCA Laboratories (IPCALAB) reported revenue ₹2,935 Cr and net profit ₹389 Cr — revenue +13.6% YoY. For annual financials, live price and key ratios, visit IPCA Laboratories share price today.

IPCALAB Quarterly Results — Revenue, Profit & EPS Highlights

IPCA Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View IPCA Laboratories yearly highs lows for the annual high/low range and current price position.

  • Revenue of ₹2,935 Cr in Sept 2026 (+18.3% vs Mar 2026, +13.6% vs Sept 2025)
  • Net Profit of ₹389 Cr in Sept 2026 (+26.7% vs Mar 2026, +38.4% vs Sept 2025)
  • EBITDA of ₹674 Cr in Sept 2026 (+26.7% vs Mar 2026)
  • Operating Margin of 22.0% in Sept 2026 (+4.0pp vs Mar 2026)
  • Earnings Per Share of ₹14.79 in Sept 2026 (+11.1% vs Mar 2026)

IPCA Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

IPCALAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 2,935 2,482 2,813 2,584 2,273 18.3% 13.6%
Net Profit (₹ Cr) 389 307 424 281 64 - -
EBITDA (₹ Cr) 674 532 695 515 250 - -
EPS (₹) 14.79 13.31 15.84 11.14 2.67 - -
Operating Margin (%) 22.0% 18.0% 24.0% 19.0% 10.0% - -

IPCALAB Share Price Trend — 1-Year Movement Across Quarterly Results

IPCA Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore IPCA Laboratories share price performance to track price trends across different timeframes.

Profitability Ratios

Profit Margin 13.3%
EBITDA Margin 23.0%
Operating Margin 22.0%
ROE (Annual) 16.3%

Balance Sheet Highlights

Total Assets ₹12,370 Cr
Total Equity ₹9,524 Cr
Current Assets ₹ Cr
Current Liabilities ₹539 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,142 Cr
Investing Cash Flow ₹-247 Cr
Financing Cash Flow ₹-754 Cr
Net Cash Flow ₹142 Cr

Current Market Data

Current Price ₹1860.00
Exchange NSE
Last Updated Nov 19, 2026

IPCALAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

IPCA Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores